Clinical Trial Update: PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a novel cannabinoid product for chronic pain; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Novel Cannabinoid Product

Snippet

Sponsor: Staci Gruber, Ph.D. | Conditions: Chronic Pain | Phase 2 | Status: RECRUITING